Clinical Trial Update: Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on liposomal bupivacaine for cesarean delivery to reduce postoperative pain has completed phases 2 and 3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Postoperative Pain After Cesarean Delivery

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pain, Postoperative | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-08-27